ACTRN12621001704886招募中未知
Imaging of Metastatic Prostate Cancer Tumors Using 68Ga-NTA-14
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- Male
入选标准
- •Male, aged 18 years or older
- •Histologically confirmed diagnosis of prostate cancer that is metastatic and castration resistant
- •Rising PSA (greater than or equal to 2 ng/dL over nadir) following curative intent therapy (surgery) or radiographic disease progression by traditional imaging (CT/MRI/bone scan)
- •Signed, written informed consent
- •Completed or undergoing treatment for mCRPC and are being considered for clinical 177Lu-PSMA I&T treatment.
- •Participants must have adequate renal function: Creatinine clearance or estimated glomerular filtration rate greater than or equal to 35 mL/min/1.73 m2 .
排除标准
- •Participants who cannot lie still for at least 30 minutes or comply with imaging procedures and study requirements.
- •Participants who are not suitable for 177Lu-PSMA I&T treatment based on investigator discretion.
研究者
相似试验
进行中（未招募）
不适用
Diagnostic imaging in prostate cancer (as in tumours with accelerated menbrane turn-over)by F-18 Fluoro-metil-choline PET/CTpatients with prostate cancer istologically provenMedDRA version: 14.1Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.1Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsEUCTR2008-003337-24-ITCENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA
已完成
不适用
Novel Imaging in Staging of Primary Prostate CancerHigh Risk Prostate CancerNCT03537391Turku University Hospital80
招募中
不适用
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancer: Phase I clinical trialKCT0004817FutureChem10
进行中（未招募）
1 期
Imaging of the prostate tumors using PET/CT and PET/MRI with the ligand of the prostatic specific membrane antigene 68Ga-PSMA-11prostatic carcinoma higly suspected or its staging or restagingEUCTR2017-004128-32-CZFakultní nemocnice Plzen200
招募中
不适用
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancerNeoplasmsKCT0003924Korea Cancer Center Hospital6